178 related articles for article (PubMed ID: 15009643)
1. DNA methylation as an epigenetic regulator of neural 5-lipoxygenase expression: evidence in human NT2 and NT2-N cells.
Zhang Z; Chen CQ; Manev H
J Neurochem; 2004 Mar; 88(6):1424-30. PubMed ID: 15009643
[TBL] [Abstract][Full Text] [Related]
2. DNA hypomethylating agents 5-aza-2'-deoxycytidine and valproate increase neuronal 5-lipoxygenase mRNA.
Manev H; Uz T
Eur J Pharmacol; 2002 Jun; 445(1-2):149-50. PubMed ID: 12065206
[TBL] [Abstract][Full Text] [Related]
3. The 5-lipoxygenase promoter is regulated by DNA methylation.
Uhl J; Klan N; Rose M; Entian KD; Werz O; Steinhilber D
J Biol Chem; 2002 Feb; 277(6):4374-9. PubMed ID: 11706027
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
[TBL] [Abstract][Full Text] [Related]
5. Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells.
Côté S; Sinnett D; Momparler RL
Anticancer Drugs; 1998 Oct; 9(9):743-50. PubMed ID: 9840718
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of 5-lipoxygenase in the phenotypic plasticity of valvular interstitial cells associated with aortic valve stenosis.
Nagy E; Bäck M
FEBS Lett; 2012 May; 586(9):1325-9. PubMed ID: 22616993
[TBL] [Abstract][Full Text] [Related]
7. On the epigenetic regulation of the human reelin promoter.
Chen Y; Sharma RP; Costa RH; Costa E; Grayson DR
Nucleic Acids Res; 2002 Jul; 30(13):2930-9. PubMed ID: 12087179
[TBL] [Abstract][Full Text] [Related]
8. Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer.
Han LL; Hou L; Zhou MJ; Ma ZL; Lin DL; Wu L; Ge YL
J Biomed Sci; 2013 Jul; 20(1):52. PubMed ID: 23899187
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells.
Angst E; Dawson DW; Nguyen A; Park J; Go VL; Reber HA; Hines OJ; Eibl G
Pancreas; 2010 Jul; 39(5):675-9. PubMed ID: 20173668
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
[TBL] [Abstract][Full Text] [Related]
11. Influence of epigenetic modifications of the interleukin-10 promoter on IL10 gene expression.
Larsson L; Thorbert-Mros S; Rymo L; Berglundh T
Eur J Oral Sci; 2012 Feb; 120(1):14-20. PubMed ID: 22288916
[TBL] [Abstract][Full Text] [Related]
12. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
Klan N; Seuter S; Schnur N; Jung M; Steinhilber D
Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of TNFA expression in periodontal disease.
Zhang S; Barros SP; Moretti AJ; Yu N; Zhou J; Preisser JS; Niculescu MD; Offenbacher S
J Periodontol; 2013 Nov; 84(11):1606-16. PubMed ID: 23368949
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic control of trefoil factor family (TFF) peptide expression in human retinoblastoma cell lines.
Philippeit C; Busch M; Dünker N
Cell Physiol Biochem; 2014; 34(3):1001-14. PubMed ID: 25199519
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
[TBL] [Abstract][Full Text] [Related]
16. Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II α.
Kim JS; Kim SY; Lee M; Kim SH; Kim SM; Kim EJ
Cancer Biol Ther; 2015; 16(4):558-66. PubMed ID: 25719218
[TBL] [Abstract][Full Text] [Related]
17. [High glucose induce the demethylation of CTGF promoter and gene expression].
Yi B; Zhang H; Zhou H; Cai X; Sun J; Liu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):747-50. PubMed ID: 21722525
[TBL] [Abstract][Full Text] [Related]
18. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
